Product Information
ERTAPENEM 1 GRAM VIAL is a generic product labeled by Fosun Pharma USA Inc., priced at $47.2056 per EA under NDC 72266015905. Its NADAC has been published 37 times since Jan 21, 2026.
FDA first approved this application on Mar 26, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/1
Manufacturer
Fosun Pharma USA Inc.NDC
72266015905
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
ERTAPENEM SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA212040FDA Approved
3/26/2021
TE Code
AP
On Market Since
11/1/2021
Pharmacological Classes
Price Statistics
The NADAC for ERTAPENEM 1 GRAM VIAL has been published 37 times since Jan 21, 2026, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $47.2056 per EA |
|---|---|
| All-time high | $58.0580 (Feb 11, 2026) |
| All-time low | $47.2056 (Sep 23, 2026) |
| 52-week high | $58.0580 |
| 52-week low | $47.2056 |
| Median price | $56.3738 |
| Average price | $55.3001 |
| Largest weekly change | -7.8% (Sep 23, 2026) |
| Weeks tracked | 37 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fosun Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ertapenem Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penem Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERTAPENEM 1 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ERTAPENEM 1 GRAM VIAL, manufactured by Fosun Pharma USA Inc., is $47.2056 per EA (NDC 72266015905), effective Sep 30, 2026.
How has the price of ERTAPENEM 1 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for ERTAPENEM 1 GRAM VIAL has declined 18.7%. It has been tracked across 37 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for ERTAPENEM 1 GRAM VIAL?
Since Jan 21, 2026, the NADAC for ERTAPENEM 1 GRAM VIAL has ranged from a low of $47.2056 (Sep 23, 2026) to a high of $58.0580 (Feb 11, 2026), with a median of $56.3738 per EA.
Are there cheaper alternatives to ERTAPENEM 1 GRAM VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERTAPENEM 1 GRAM VIAL, is $26.6295 per EA — about 44% below ERTAPENEM 1 GRAM VIAL.
Who manufactures ERTAPENEM 1 GRAM VIAL?
ERTAPENEM 1 GRAM VIAL (NDC 72266015905) is labeled by Fosun Pharma USA Inc., and CMS classifies it as a generic product.